Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 216 clinical trials
Neoadjuvant mFOLFOXIRI Plus Bevacizumab With Selective Radiotherapy in Patients With High-Risk Locally Advanced Rectal Cancer

A small single-center phase II pilot trial treated patients with stage II or III rectal cancer with induction FOLFOX/bevacizumab chemotherapy followed by CRT only in those with stable or progressive disease and resection in all patients. All 32 of the participants had an R0 resection, and the 4-year DFS was …

rectal cancer
primary tumor
metastatic colorectal cancer
colorectal cancer
total mesorectal excision
  • 0 views
  • 16 Feb, 2024
  • 1 location
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients

This is an open-label, non-randomised, phase II, exploratory, multi-country and multi-centre clinical trial. Chemotherapy-nave patients with EML4-ALK rearrangement and with locally advanced or metastatic non-small cell lung cancer patients will be selected.

coronary artery disease
stroke
heart failure
stage iv non-small cell lung cancer
platelet count
  • 0 views
  • 16 Feb, 2024
  • 15 locations
Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma

In patients with locally advanced oral squamous cell carcinoma (OSCC), due to the large tumor burden and neck lymph node metastasis, comprehensive treatment is recommended, including surgery, radiotherapy, chemotherapy and others. Pre-operative inductive therapy can reduce tumor volume, increase organ retention rate, and reduce distant metastasis rate.

squamous cell carcinoma of the head and neck
immune checkpoint inhibitor
tumor angiogenesis
tumor growth
immunosuppression
  • 0 views
  • 05 Aug, 2020
Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL

This study was a prospective, multi-center, single-arm, Phase II clinical study. Compared with the literature data, objective response rate (ORR) and complete response rate (CR) were the primary endpoint, and 1-year and 2-year progression-free survival (PFS) and 2-year overall survival (OS) were the secondary endpoint. To evaluate the efficacy and …

  • 0 views
  • 21 Sep, 2021
  • 1 location
Short Structured Psychological Intervention for Adults With ADHD - a Randomized Controlled Trial

The purpose of this study is to evaluate the effects of a novel psychological intervention for adult ADHD through a randomized controlled trial. Participants will be randomized to receive either a face-to-face manualized short psychological intervention, SAINT, or corresponding self-help material with limited access to therapist support. The main objective …

cns stimulants
psychiatric symptoms
substance use
attention deficit hyperactivity disorder
stimulant
  • 0 views
  • 05 Aug, 2020
STunning in Acute Myocardial Infarction - BAS (STAMI-BAS)  

The objective of this trial is to examine the effect of immediate versus late administration of beta blockers, angiotensin converting enzyme inhibitors (ACEI), and sodium/glucose cotransporter 2 (SGLT2) inhibitors on echocardiographic parameters and biomarkers in subjects with ST-elevation myocardial infarction (STEMI)

  • 0 views
  • 01 May, 2025
Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia

A multicenter randomized, double-blind, placebo-controlled clinical trial of Convalescent SARS COVID-19 plasma versus Placebo to evaluate the effect between arms on an ordinal score of six mutually exclusive categories of clinical status at day 30 after study initiation.

ct scan
pneumonia
covid-19
acute respiratory syndrome (sars)
SARS
  • 0 views
  • 01 Feb, 2023
  • 1 location
Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer

This is a randomised, double-blinded, placebo-controlled, multi-center phase III trial, comparing the efficacy and safety of treatment with Camrelizumab (SHR-1210) + definitive chemoradiotherapy(dCRT) vs placebo+dCRT for locally advanced esophageal cancer patients in China. Camrelizumab (SHR-1210) is a humanized anti-PD1 IgG4 monoclonal antibody.

antibody therapy
monoclonal antibodies
cancer
esophageal cancer
monoclonal antibody therapy
  • 0 views
  • 16 Feb, 2024
  • 1 location
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-na ve GBM Patients.

A multi-center, open-label, single-arm, phase I/II clinical study is designed to test the safety and immunogenicity of an investigational Dendritic and Glioma Cells Fusion vaccine given with IL-12 for treatment-nave patients after resection of glioblastoma.

temozolomide
white blood cell count
glioma
glioblastoma multiforme
ejection fraction
  • 0 views
  • 05 Aug, 2020
tDCS Intervention on Motivational Anhedonia of Major Depressive Disorder

Study of tDCS intervention on motivational anhedonia of Major Depressive Disorder

selective serotonin reuptake inhibitors
electroconvulsive therapy
psychiatric disorder
depression
ssris
  • 0 views
  • 16 Feb, 2024
  • 1 location